168 related articles for article (PubMed ID: 37410097)
1. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes.
Araujo-Castro M; Paja Fano M; Pla Peris B; González Boillos M; Pascual-Corrales E; García-Cano AM; Parra Ramírez P; Rojas-Marcos PM; Ruiz-Sanchez JG; Vicente A; Gómez-Hoyos E; Ferreira R; García Sanz I; Recasens M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo C; Manjón L; García-Centeno R; Percovich JC; Rebollo Román Á; Gracia Gimeno P; Robles Lázaro C; Morales M; Calatayud M; Collao SAF; Meneses D; Sampedro Nuñez MA; Escudero Quesada V; Ribas EM; Sanmartín Sánchez A; Diaz CG; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano J; Michalopoulou T; Moya Mateo EM; Hanzu F
Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37410097
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic risk in patients with primary aldosteronism and autonomous cortisol secretion. Case-control study.
Araujo-Castro M; Bengoa Rojano N; Fernández Argüeso M; Pascual-Corrales E; Jiménez Mendiguchía L; García Cano AM
Med Clin (Barc); 2021 Nov; 157(10):473-479. PubMed ID: 33039136
[TBL] [Abstract][Full Text] [Related]
4. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
[TBL] [Abstract][Full Text] [Related]
6. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
7. Cortisol-producing adenoma-related somatic mutations in unilateral primary aldosteronism with concurrent autonomous cortisol secretion: their prevalence and clinical characteristics.
Wu WC; Peng KY; Lu JY; Chan CK; Wang CY; Tseng FY; Yang WS; Lin YH; Lin PC; Chen TC; Huang KH; Chueh JS; Wu VC
Eur J Endocrinol; 2022 Oct; 187(4):519-530. PubMed ID: 35900323
[TBL] [Abstract][Full Text] [Related]
8. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
[TBL] [Abstract][Full Text] [Related]
9. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
[TBL] [Abstract][Full Text] [Related]
10. New-onset diabetes mellitus risk associated with concurrent autonomous cortisol secretion in patients with primary aldosteronism.
Wu VC; Chan CK; Wu WC; Peng KY; Chang YS; Yeh FY; Chiang JY; Lee YJ; Liu KL; Wang SM; Lin YH; Chueh JS;
Hypertens Res; 2023 Feb; 46(2):445-455. PubMed ID: 36481967
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
12. Influence of cortisol cosecretion on non-ACTH-stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study.
Heinrich DA; Quinkler M; Adolf C; Handgriff L; Müller L; Schneider H; Sturm L; Künzel H; Seidensticker M; Deniz S; Ladurner R; Beuschlein F; Reincke M
Eur J Endocrinol; 2022 Nov; 187(5):637-650. PubMed ID: 36070424
[TBL] [Abstract][Full Text] [Related]
13. Autonomous cortisol secretion is associated with worse arterial stiffness and vascular fibrosis in primary aldosteronism: a cross-sectional study with follow-up data.
Tsai CH; Liao CW; Wu XM; Chen ZW; Pan CT; Chang YY; Lee BC; Shun CT; Wen WF; Chou CH; Wu VC; Hung CS; Lin YH
Eur J Endocrinol; 2022 Jun; 187(1):197-208. PubMed ID: 35551115
[TBL] [Abstract][Full Text] [Related]
14. Latent Autonomous Cortisol Secretion From Apparently Nonfunctioning Adrenal Tumor in Nonlateralized Hyperaldosteronism.
Ohno Y; Sone M; Inagaki N; Takeda Y; Kurihara I; Tsuiki M; Ichijo T; Wada N; Katabami T; Ogawa Y; Okamura S; Fukuoka T; Kai T; Izawa S; Yoshikawa Y; Hashimoto S; Yamada M; Chiba Y; Naruse M;
J Clin Endocrinol Metab; 2019 Oct; 104(10):4382-4389. PubMed ID: 31058960
[TBL] [Abstract][Full Text] [Related]
15. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
[TBL] [Abstract][Full Text] [Related]
16. Influence of autonomous cortisol secretion in patients with primary aldosteronism: subtype analysis and postoperative outcome.
Hung K; Lee BC; Chen PT; Liu KL; Chang CC; Wu VC; Lin YH
Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37800679
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
Araujo-Castro M; García Cano A; Jiménez Mendiguchía L; Escobar-Morreale HF; Valderrábano P
Sci Rep; 2021 Oct; 11(1):20539. PubMed ID: 34654835
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
[TBL] [Abstract][Full Text] [Related]
19. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
Rebelo JFD; Costa JM; Junqueira FD; Fonseca AO; de Almeida ABABS; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion.
Nakajima Y; Yamada M; Taguchi R; Satoh T; Hashimoto K; Ozawa A; Shibusawa N; Okada S; Monden T; Mori M
J Clin Endocrinol Metab; 2011 Aug; 96(8):2512-8. PubMed ID: 21593113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
